AMERICAN VANGUARD CORP director and CEO Douglas Kaye received a grant of 50,000 stock options. These options allow the purchase of 50,000 shares of Common Stock at an exercise price of $2.51 per share. The award is compensation-related, not an open-market trade.
The incentive stock options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary. After this grant, Kaye holds 50,000 options directly, giving potential future equity exposure if the options vest and are exercised.
American Vanguard Corporation reported the results of its 2026 annual stockholder meeting and approved special executive bonuses. Seven director nominees were elected, Deloitte Touche LLP was ratified as independent auditor for the year ending December 31, 2026, and stockholders backed annual advisory votes on pay and approved the company’s executive compensation program. The board also granted success bonuses tied to a full restructuring of the company’s borrowed debt: $150,000 to Douglas Kaye, $125,000 each to David Johnson and Timothy Donnelly, and $50,000 to Shirin Khosravi.
American Vanguard Corp’s chief executive officer, Douglas Kaye, bought additional company stock in the open market. On this transaction, the CEO purchased 5,000 shares of Common Stock at a price of $2.50 per share. After the purchase, his directly owned stake increased to 300,251 shares.
McDougal Rubin J reported acquisition or exercise transactions in this Form 4 filing.
AMERICAN VANGUARD CORP director Rubin J. McDougal received 31,872 deferred stock units (DSUs) as compensation. The award was granted in connection with the company’s 2026 annual stockholders’ meeting and is recorded at no cash cost per unit.
Each DSU represents the right to receive one share of common stock when the award settles. Settlement occurs at the earlier of the director leaving the board, a change of control, or the director’s death. Until then, the DSUs are nontransferable and carry no voting or dividend rights.
AMERICAN VANGUARD CORP director Rubin J. McDougal has filed an initial statement of beneficial ownership on Form 3. The filing lists him as a director but shows no reported transactions, meaning it simply establishes his status as an insider without disclosing any recent trades.
American Vanguard Corp’s Chief Commercial Officer, Michael Joseph DiPaola, received an incentive stock option grant. The award covers 20,000 options to buy common stock at an exercise price of $2.51 per share.
The options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary, June 4, 2036, if not exercised. This is a compensation-related equity grant rather than an open-market share purchase or sale.
AMERICAN VANGUARD CORP director Patrick E. Gottschalk received a grant of 31,872 deferred stock units. These DSUs were awarded as part of the compensation program for non-management directors in connection with the 2026 annual stockholders' meeting, at no cash cost per unit. Following the award, Gottschalk holds 223,577 shares or units of common stock-related interests directly. Each DSU converts into one share of common stock upon settlement, which occurs when his board service ends, upon a change of control, or upon his death.
American Vanguard Corp senior vice president Jared Straley received a grant of options to buy 20,000 shares of common stock. The incentive stock options have an exercise price of $2.51 per share, vest in full on the third anniversary of the June 4, 2026 grant, and expire on June 4, 2036.
American Vanguard Corp CHRO Shirin Khosravi received a grant of options to buy 20,000 shares of common stock. These incentive stock options have an exercise price of $2.51 per share and relate to 20,000 underlying common shares.
The options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary, June 4, 2036. Following this award, Khosravi holds options to acquire 20,000 shares directly, reflecting a compensation-related equity grant rather than an open-market purchase or sale.
AMERICAN VANGUARD CORP senior vice president of manufacturing Gilliam Nolteanous received a grant of stock options. The award covers 20,000 options to buy common stock at an exercise price of $2.51 per share.
These incentive stock options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary, June 4, 2036. Following this grant, Nolteanous holds 20,000 options directly, reflecting compensation rather than an open-market share purchase.